# Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-trial-of-four-cisplatin-containing-doublet-combinations-in-stage-ivb/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bradley J. Monk,Michael W. Sill,D. Scott McMeekin,David E. Cohn,Lois M. Ramondetta,Cecelia H. Boardman,J Bénda,David Cella |
| Citations | 693 |
| DOI | 10.1200/jco.2009.21.8909 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.21.8909?role=tab |
| OpenAlex ID | https://openalex.org/W2118508302 |
| PMID | 19720909 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)
- [David Cella](https://scholariq.org/researchers/david-cella/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Bioactive Compounds and Antitumor Agents](https://scholariq.org/topics/bioactive-compounds-and-antitumor-agents/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.